Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53
Published May 1, 2024 · Recall initiated: March 26, 2024
Summary
FDA records drug Class II recall D-0471-2024, published May 1, 2024 and initiated March 26, 2024. Recalling firm: Cipla USA, Inc.; Status: Terminated; Reported quantity: 59244/3ml FFS packs; Lot: Lot # IA30390, Exp 4/30/2025, IA30517, Exp 6/30/ 2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
- Manufacturer
- Cipla USA, Inc.
- Distributor
- USA nationwide.
- Lot
- Lot # IA30390, Exp 4/30/2025, IA30517, Exp 6/30/ 2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister card.May 1, 2024
- FDADiltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, RxMay 1, 2024
- FDAAbilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical,May 1, 2024
- FDACloderm (clocortolone pivalate) Cream, 0.1%, Rx Only, For Topical Use Only, Net Wt 45g, Manufactured for: EPIMay 1, 2024
- FDAIpratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL SterileJanuary 3, 2024
- FDAIpratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution 3mL vial, packaged in a) 30-countJune 15, 2022
Questions about this recall
Was Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton containing 30 vials ( 6 pouches of 5 - 3 mL vials), Rx only, Manufactured by: Cipla Ltd., Indore SEZ, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-173-53 recalled?
Yes. FDA published recall D-0471-2024 on May 1, 2024. Reported hazard: Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE.